Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Mar. 19, 2012	Dec. 31, 2011
Investments held in trust, at fair value:
Fixed-maturity securities	$ 52,578	$ 145,904
Cash equivalents held in trust	11,122	33,093
Total investments held in trust	63,700	178,997
Cash and cash equivalents	78,009	11,986
Fixed-maturity securities, at fair value	8,063	72,897
Restricted cash	2,447	115
Accrued investment income	476	1,110
Deferred offering costs	2,568	1,071
Other assets	876	1,462
Total assets	156,139	267,638
Liabilities:
Notes payable - principal	31,220	105,502
Notes payable - interest	338	1,143
Losses and loss adjustment reserves	18,947	44,314	82,524		142,119
Losses payable	696	2,517
Unearned premiums	1,094	1,394
Accrued ceding commissions	44	102
Loss contract fair market value reserve	12,549	46,319		63,100
Other liabilities	3,021	1,218
Total liabilities	67,909	202,509
Commitments and contingencies
Shareholders’ equity:
Convertible preferred stock, $0.00001 par value; 5,000,000 authorized; 1,000,000 and zero shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively
Common stock, $0.00001 par value; 500,000,000 authorized; 202,343,245 and 201,842,351 shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively	2	2
Additional paid-in capital	106,628	77,142		76,598
Accumulated (deficit)	(18,400)	(12,015)
Total shareholders’ equity	88,230	65,129
Total liabilities and shareholders’ equity	$ 156,139	$ 267,638